(R)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride

Catalog No. :
ACOEZU069
CAS No. :
1315053-41-8
Molecular Formula :
C5H9ClF2N2O
Molecular Weight :
186.59

IUPAC Name:(R)-4,4-difluoropyrrolidine-2-carboxamide hydrochloride

(R)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$66.00Login to see priceIn stockInquiry
1g95%$168.00Login to see priceIn stockInquiry
5g95%$553.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride
IUPAC Name(R)-4,4-difluoropyrrolidine-2-carboxamide hydrochloride
MDL No.MFCD06797015
Molecular FormulaC5H9ClF2N2O
Molecular Weight186.59
SMILESO=C([C@@H]1NCC(F)(F)C1)N.[H]Cl
InChI KeyRRQDQYAEZGKHOB-AENDTGMFSA-N
Synonym4,4-DIFLUORO-D-PROLINAMIDE HYDROCHLORIDE | (R)-4,4-Difluoropyrrolidine-2-carboxamidehydrochloride | 4,4-Difluoro-D-prolinamide--hydrogen chloride (1/1) | D79336 | A888417 | SCHEMBL15776372 | (R)-4,4-Difluoropyrrolidine-2-carboxamide hydrochloride | AKOS00
CAS No.1315053-41-8
PubChem CID45158907

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACOEZU069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOEZU069 route product structure diagram
    ACOEZU0691315053-41-8 In Stock
Inquiry

2. ACOEZU069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOEZU069 route product structure diagram
    ACOEZU0691315053-41-8 In Stock
Inquiry

Comments (0)